Lowering Blood Pressure in Primary Care in Vienna
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 229 participants.
Also called NCT02377661
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 229 participants
- Sponsor
- Wilhelminenspital Vienna
- Registry
-
NCT02377661
-
- Other papers using this trial's data
- Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria
- Registry status
- Completed
Technical summary
Registry record NCT02377661. Randomized; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2017-05-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lowering Blood Pressure in Primary Care in Vienna
- Acronym
- Low BP Vienna
- Condition
- Hypertension
- Intervention (Drug)
- Olmesartan medoxomil, amlodipine, hydrochlorothiazide
- Lead sponsor
- Wilhelminenspital Vienna
- Collaborator
- Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology
- Collaborator
- Ludwig Boltzmann Institute for Cardiovascular Research
Record details
- Record id
cardio:ct-nct02377661- Content hash
65334f004875c8536840d5fba2eba110af69ea135e482b8074c4dd3f9ac1c267